期刊文献+

28例复发难治性多发性骨髓瘤患者行嵌合抗原受体T细胞免疫疗法的效果观察及护理 被引量:11

Clinical observation and nursing care to patients with relapsed or refractory myeloma by chimeric antigen receptor T cell therapy
下载PDF
导出
摘要 目的总结嵌合抗原受体T细胞(chimeric antigen receptor T-cell,CAR-T)免疫疗法治疗复发难治性多发性骨髓瘤(multiple myeloma,MM)的护理要点。方法对28例复发难治性MM行CAR-T免疫疗法,在治疗中对患者实施心理护理、静脉用药护理、饮食护理、预防感染和细胞因子释放综合征的观察和护理。结果 28例患者治疗总有效率92.9%。未发生护理相关并发症。结论 CAR-T治疗难治复发性MM效果是确切的。做好心理护理可使患者处于最佳的心理状态接受治疗;预处理的护理和对细胞因子释放综合征的观察及护理对保证疾病的治疗效果具有重要意义。 Objective To summarize the nursing measures for patients with recurrent refractory multiple myeloma(MM)treated with chimeric antigen receptor T(CAR-T) cell immunotherapy. Method Psychological nursing, intravenous medication nursing, diet nursing, bone marrow suppression nursing and cytokine releasing syndrome nursing performed to 28 patients with recurrent refractory MM. Results The total effective rate of 28 patients was 92.9%. No nursing complications occurred. Conclusions CAR-T is effective in the treatment of refractory recurrent MM. The pertinent mental care helps the patients to live through the treatment in a good condition. Pre-treatment nursing and bone marrow suppression nursing care is important for an ensured therapeutic effect.
作者 梁美萍 张琳 赵万红 张娟利 臧昕昭 许龙 邓春娥 Liang Meiping;Zhang Lin;Zhao Wanhong;Zhang Juanli;Zang Xinzhao;Xu Long;Deng Ghunxe(Department of Hematopathology,the Second Affiliated Hospital of Xi'an Jiaotong University,Xixan,710004,China)
出处 《现代临床护理》 2018年第5期40-45,共6页 Modern Clinical Nursing
关键词 多发性骨髓瘤 嵌合抗原受体T细胞免疫疗法 护理 multiple myeloma Chimeric antigen receptor T cell immunotherapy nursing
  • 相关文献

参考文献5

二级参考文献66

  • 1范小红,韩宝惠.恶性胸腔积液的治疗[J].中国呼吸与危重监护杂志,2005,4(3):179-180. 被引量:31
  • 2谢加富,李伟峰.中心静脉导管置管引流气胸和胸腔积液的临床应用[J].实用医学杂志,2007,23(13):2066-2067. 被引量:26
  • 3Khan MS,Holmes JD.Redueing the morbidity from extravasation injuries[J]. Ann Plast surg,2002,48(6): 628-632.
  • 4李俊英 余春华 付岚 等.化疗药物外渗的危险因素及预防.中国实用护理杂志,2003,12(19):211-211.
  • 5Skhvatsabaja LV. Secondary malignant lesions of the heart and pericardium in neoplastic disease[J].Oncology(Basel),1986.103-106.
  • 6Ratta M,Curti A,Fogli M. Efficient presentation of tumor idiotype to autologous Tcells by CD83(+)dendritic cellsderived from highly purified circulating CD14(+)monocytes in multiple myeloma patients[J].ExpHemato,1200.931-940.
  • 7Triozzi PL,Khurram R,Aldrich WA. Intraumoral injectionofdendritic cells derivedin vitroin patientswithmetastatic cancer[J].Cancer,2000.2646-2654.
  • 8Deniger DC, Switzer K, Mi T, et al. Bispecific T-cells express- ing polyclonal repertoire of endogenous gammadelta T-cell recep-tors and introduced CD19-specific chimeric antigen receptor [J]. Molecular therapy: the journal of the American Society of Gene Therapy, 2013, 21(3): 638-647.
  • 9Jena B, Dotti G, Cooper LJ. Redirecting T-cell specificity by in- troducing a tumor-specific chimeric antigen receptor [J]. Blood, 2010, 116(7): 1035-1044.
  • 10Wang J, Jensen M, Lin Y, etal. Optimizing adoptive polyclonal T cell immunotherapy of lymphomas, using a chimeric T cell re- ceptor possessing CD28 and CD137 costimulatory domains [J]. Human gene therapy, 2007, 18(8): 712-725.

共引文献37

同被引文献112

引证文献11

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部